Genenta Science S.p.A. (SAEN)
Genenta Science S.p.A. operates as a strategic consolidator that focuses on acquiring ownership of privately held companies operating in Italian national-security-regulated sectors. Its activities and acquisition strategy covers aerospace, defense, national security, and biotechnology/biosecurity. Genenta Science S.p.A. was incorporated in 2014 and is headquartered in Milan, Italy.
Sector: Biological Products, (No Diagnostic Substances)
Industry: Conglomerates
Genenta Science S.p.A.
NASDAQ:SAENIndustrials · Aerospace & Defense
-3.83%$0.5770
CLOSED · Nov 17Prev close$0.6000-3.83%Close$0.5770+17.85%AH close$0.6800
AH$0.6800+17.85%vs close
Mkt Cap$27.82M
EV-
Float15.69M
O/S48.22M
VOL46K sh
$ Vol$28K
RVOL0.33×
Inst Own-
SI0.5%
Net Cash/Sh-
EarningsMar 3 · in 4mo
Dilution
MCap$27.82MFloat15.69MO/S48.22M
Dilution
Genenta Science S.p.A. (SAEN) dilution facts from SEC filings
Snapshot as of Dec 31, 2025, built from 37 SEC filings.
- Shelf registration
- None on file in the filings reviewed
- At-the-market (ATM) program
- No active program in the filings reviewed
- Warrants outstanding
- 1 warrant series recorded as outstanding
- Most recent offering
- Not measured
Check another stock for dilution
Facts as recorded in the company's SEC filings. The full snapshot, with instrument terms, share counts and history, is part of Signal8 Pro.